Chester County News and Community Website
WILMINGTON, DE — AstraZeneca’s (NYSE: AZN) Tagrisso showed a sustained survival benefit eight years after treatment in a Phase III trial of patients with early-stage EGFR-mutated non-small cell lung cancer, …
Tagrisso Cuts Death Risk 47% in Long-Term Lung Cancer Trial Read More
WILMINGTON, DE — Exicure Inc. (Nasdaq: XCUR) has until Dec. 2 to restore compliance with Nasdaq’s minimum stockholders’ equity requirement, giving the company additional time to address a listing deficiency …
Exicure Gets Nasdaq Extension as Delisting Risk Persists Read More
WILMINGTON, DE — NRx Pharmaceuticals Inc. (Nasdaq: NRXP) received a revised Nov. 10 regulatory goal date for its preservative-free ketamine application after the U.S. Food and Drug Administration reclassified a …
NRx Gets Earlier FDA Goal Date for Ketamine Application Read More
WILMINGTON, DE — Chase and Air Canada are expanding rewards and travel benefits on the Chase Air Canada Aeroplan Card, increasing earn rates and adding automatic elite status as competition …
Chase, Air Canada Raise Rewards Stakes on Aeroplan Card Read More
WILMINGTON, DE — Uplynk is adding a managed operations layer around AWS Elemental video infrastructure, targeting streaming providers that want to reduce the engineering work required to deploy and operate …
Uplynk Targets Streaming Complexity With AWS Managed Layer Read More WILMINGTON, DE — AstraZeneca’s Imfinzi combined with Amgen’s tarlatamab significantly extended overall survival in a Phase III trial of first-line extensive-stage small cell lung cancer, potentially expanding treatment options for …
AstraZeneca Lung Cancer Combo Extends Survival in Phase III Read More WILMINGTON, DE — AstraZeneca’s experimental COPD drug tozorakimab reduced moderate and severe exacerbations by as much as 34% in two Phase III trials across a broad patient population, supporting a …
AstraZeneca COPD Drug Cuts Exacerbations in Phase III Read More
WILMINGTON, DE — Diversified, LLC, a registered investment advisor, has been named to Quartz’s Best Places to Work 2026 list, which recognizes eight U.S. companies for how they are run …
Diversified Named to Best Places to Work by Quartz 2026 Read More WILMINGTON, DE — NRx Pharmaceuticals Inc. said its HOPE Therapeutics subsidiary will become the first interventional psychiatry network to deploy Zeta Surgical’s newly FDA-cleared robotic transcranial magnetic stimulation system, expanding …
HOPE Adds Robotic TMS System Ahead of SPARC Trial Read More
WILMINGTON, DE — Prelude Therapeutics Inc. (Nasdaq: PRLD) received U.S. Food and Drug Administration clearance to begin a Phase 1 trial of PRT13722, moving its experimental KAT6A-targeting breast cancer drug …
Prelude Wins FDA Clearance to Move Breast Cancer Drug to Trial Read More